Short–Term Preconditioning with Insulin and Glucose Efficiently Protected the Kidney Against Ischemia-Reperfusion Injury via the P-AKT-Bax-Caspase-3 Signaling Pathway in Mice
DOI: https://doi.org/10.2147/dddt.s465836
IF: 4.3188
2024-06-20
Drug Design Development and Therapy
Abstract:Liwei Sun, 1, &ast Hailong Bing, 1, &ast Chenxi Zhang, 1, &ast Lin Lin, 2 Hongkai Lian, 2 Qinjun Chu, 1 Xiaogao Jin 1, 3 1 Department of Anesthesiology and Perioperative Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, People's Republic of China; 2 Research of Trauma Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, People's Republic of China; 3 Department of Anesthesiology, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaogao Jin; Liwei Sun, Email ; Objective: Insulin attaches insulin receptor to activate the PI3-kinase/Akt signaling to maintain glucose homeostasis and inhibit apoptosis. This study determined whether preconditioning with insulin and glucose protects the kidney against ischemia-reperfusion injury (IRI). Methods: Kidney IRI was performed in C57BL/6 mice by clamping the renal vessels for 30 min, followed by reperfusion for 24 h. A total subcutaneous 0.1 unit of insulin along with 10% glucose in drinking water was treated on the mice for 24 h before kidney IRI. The kidney function and injuries were investigated through the determination of BUN and Cr in blood plasma, as well as the apoptosis and the expression of P-AKT, BAX, and caspase-3 in the kidneys. The role of P-AKT in insulin-treated IRI kidneys was tested using an AKT inhibitor. The effects of the preconditional duration of insulin and glucose on IRI kidneys were investigated by expanding the treatment duration to 1, 3, and 6 days. Results: Preconditioning with insulin and glucose protected the kidney against IRI as manifested by a decrease in creatinine and BUN and a reduction of kidney tubular injury. The protection effect was mediated by P-AKT-BAX-caspase-3 signaling pathway resulting in suppression of apoptotic cell death. An AKT inhibitor partially reversed the protective effects of preconditional insulin. The preconditional duration for 1, 3, and 6 days had no differences in improving kidney functions and pathology. Conclusion: A short-term preconditioning with insulin and glucose protected the kidney from IRI through the activation of p-AKT and subsequent reduction of BAX-caspase-3-induced apoptosis. The short-term precondition provides a practicable strategy for protecting the kidney against predictable IRI, such as kidney transplant and major surgical operations with high risk of hypotension. Keywords: kidney, insulin, ischemia-reperfusion injury, AKT, Bax, caspase-3 Acute kidney injury caused by ischemia-reperfusion is a common condition in multiple clinical settings such as septic shock, trauma, kidney transplantation, and cardiovascular surgery. 1–3 Acute kidney injury could lead to high mortality and a lengthy ICU stay. 3,4 Aggressive prevention of acute kidney injury remarkably reduces mortality and medical expenses for critically ill patients. 5 Insulin has been shown to prevent human renal tubular epithelial cells from camptothecin-induced apoptosis through the activation of the PI3-kinase/Akt pathway. 6 Insulin attaches insulin receptor to activate the PI3-kinase/Akt/AS160(or GSK3) signaling to maintain glucose homeostasis. Subsequently phosphorylated AS160 translocate GLUT4 to cellular membrane to uptake glucose and phosphorylated GSK3 increased glycogen synthesis. 7 The insulin/insulin receptor/PI3-kinase/Akt signaling was also found inhibition of hypoxic-ischemic-induced apoptosis through inhibiting autophagy and endoplasmic reticulum stress. 8 Therefore, insulin is usually used to preserve the vitality of renal tubular epithelial cells in culture. 9 In rats with diabetes mellitus (DM), insulin treatment before ischemia-reperfusion injury (IRI) preserved both renal function and histomorphology, whereas insulin treatment after IRI had no such protective effects. 10 Fei Tong et al reported that preconditioning with insulin improved the recovery of renal dysfunction in DM rats after kidney IRI. 11 In a normal glucose animal model, 96 h of glucose-insulin infusion before and after IRI was found to protect the kidney against IRI. However, the glucose-insulin infusion for such a long time in rats is difficult to translate into clinical practice. This study did not confirm whether the glucose-insulin infusion before IRI protects the kidney against IRI. Moreover, this experiment did not explore how insulin and glucose prevent ischemic-reperfusion-induced kidney damage. 12 In the cli -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal